Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation

Megumi Funakoshi-Tago, Seisho Yu, Akira Kushida, Kazusane Takeuchi, Hiroomi Tamura

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'Kampo medicines, Rokumigan, Hachimijiogan, and Goshajinkigan, significantly inhibit glucagon-induced CREB activation'. Together they form a unique fingerprint.

Chemical Compounds